PM Janaushadhi Kendras-like stores for animal medicines on the cards

The Janaushadhi Kendras are a collaboration between government agencies and private entrepreneurs

animals, tigers, coronavirus vaccine, covid-19
Representative Image
Sanjeeb Mukherjee New Delhi
3 min read Last Updated : Oct 08 2023 | 11:24 PM IST
Following the remarkable success of the Pradhan Mantri Janaushadhi Kendras, sources have revealed that the Centre is actively working on a proposal to establish Pashudhan Aushadhi Kendras. These centres aim to retail generic animal and veterinary medicines at highly affordable rates.

The total funds allocated for the scheme and the number of stores to be set up in the initial phase are still being woarked out.

Similar to the Janaushadhi Kendras, these Pashudhan Aushadhi Kendras will be operated jointly by government agencies and private entrepreneurs.

Sources suggest that a Cabinet note detailing the proposal is being prepared and may offer additional insi­ghts. They have indicated that Pashudhan Aushadhi Kendras, similar to Janaushadhi Kendras, are expected to primarily offer generic medicines at affordable rates, specifically tailored for animals and livestock

Some sources suggest that this initiative may enhance rural outreach, with most of these stores likely to be located in rural areas. This strategic placement will benefit animal farmers and livestock rearers, thus bolstering agricultural communities.

In line with the Janaushadhi Kendras, the Pashudhan Aushadhi Kendras will also create employment opportunities for rural youth and individuals from rural and semi-urban areas.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the Department of Pharm­aceuticals under the Ministry of Chemicals & Fertilizers in November 2008. This initiative involves the establishment of dedicated outlets known as Janaushadhi Kendras, where generic medicines are made available at affordable rates. As of March 31, 2023, there were approximately 9,303 operational Janaushadhi Kendras across India. The product basket includes 1,800 drugs and 285 surgical items, although these figures have likely increased since then. The scheme is administered by a society registered under the Societies Regis­tration Act, namely the Pha­rm­aceuticals & Medical Devices Bureau of India.

The primary objectives of these stores are to ensure access to quality medicines for all segments of the population, particularly the economically disadvantaged. Additionally, the initiative aims to raise awareness about generic medicines through educational campaigns and publicity efforts, countering the misconception that quality is always associated with high prices. Moreover, it aims to generate employment by encouraging individual entrepreneurs to open these stores. 

For Janaushadhi Kendras, the Centre offers incentives for monthly purchases up to a certain limit, as well as a one-time grant to acquire furniture, computers, and printers for the store.

The prices of generic medicines in Janaushadhi Kendras are approximately 50–90 per cent lower than the prices of branded medicines in the open market.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :MedicinesPharmaceuticalFertilizersAnimals

Next Story